chr20-58445517-A-G

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_004738.5(VAPB):​c.*1282A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.165 in 454,294 control chromosomes in the GnomAD database, including 7,150 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 2090 hom., cov: 32)
Exomes 𝑓: 0.17 ( 5060 hom. )

Consequence

VAPB
NM_004738.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 3.47

Publications

11 publications found
Variant links:
Genes affected
VAPB (HGNC:12649): (VAMP associated protein B and C) The protein encoded by this gene is a type IV membrane protein found in plasma and intracellular vesicle membranes. The encoded protein is found as a homodimer and as a heterodimer with VAPA. This protein also can interact with VAMP1 and VAMP2 and may be involved in vesicle trafficking. [provided by RefSeq, Jul 2008]
VAPB Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 8
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • adult-onset proximal spinal muscular atrophy, autosomal dominant
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.26).
BP6
Variant 20-58445517-A-G is Benign according to our data. Variant chr20-58445517-A-G is described in ClinVar as Benign. ClinVar VariationId is 338947.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.297 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VAPBNM_004738.5 linkc.*1282A>G 3_prime_UTR_variant Exon 6 of 6 ENST00000475243.6 NP_004729.1 O95292-1Q53XM7
VAPBNR_036633.2 linkn.2060A>G non_coding_transcript_exon_variant Exon 4 of 4
VAPBNM_001195677.2 linkc.*1352A>G 3_prime_UTR_variant Exon 3 of 3 NP_001182606.1 O95292-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VAPBENST00000475243.6 linkc.*1282A>G 3_prime_UTR_variant Exon 6 of 6 1 NM_004738.5 ENSP00000417175.1 O95292-1

Frequencies

GnomAD3 genomes
AF:
0.158
AC:
23973
AN:
152026
Hom.:
2086
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.154
Gnomad AMI
AF:
0.181
Gnomad AMR
AF:
0.0827
Gnomad ASJ
AF:
0.170
Gnomad EAS
AF:
0.310
Gnomad SAS
AF:
0.255
Gnomad FIN
AF:
0.273
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.140
Gnomad OTH
AF:
0.134
GnomAD2 exomes
AF:
0.163
AC:
22236
AN:
136630
AF XY:
0.171
show subpopulations
Gnomad AFR exome
AF:
0.158
Gnomad AMR exome
AF:
0.0563
Gnomad ASJ exome
AF:
0.169
Gnomad EAS exome
AF:
0.305
Gnomad FIN exome
AF:
0.261
Gnomad NFE exome
AF:
0.138
Gnomad OTH exome
AF:
0.138
GnomAD4 exome
AF:
0.168
AC:
50753
AN:
302152
Hom.:
5060
Cov.:
0
AF XY:
0.179
AC XY:
30767
AN XY:
172210
show subpopulations
African (AFR)
AF:
0.159
AC:
1363
AN:
8548
American (AMR)
AF:
0.0558
AC:
1521
AN:
27270
Ashkenazi Jewish (ASJ)
AF:
0.172
AC:
1860
AN:
10786
East Asian (EAS)
AF:
0.317
AC:
2921
AN:
9210
South Asian (SAS)
AF:
0.250
AC:
14874
AN:
59602
European-Finnish (FIN)
AF:
0.250
AC:
3200
AN:
12790
Middle Eastern (MID)
AF:
0.142
AC:
163
AN:
1150
European-Non Finnish (NFE)
AF:
0.143
AC:
22681
AN:
158752
Other (OTH)
AF:
0.155
AC:
2170
AN:
14044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
3028
6055
9083
12110
15138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.158
AC:
23983
AN:
152142
Hom.:
2090
Cov.:
32
AF XY:
0.166
AC XY:
12326
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.154
AC:
6390
AN:
41526
American (AMR)
AF:
0.0825
AC:
1262
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.170
AC:
589
AN:
3468
East Asian (EAS)
AF:
0.310
AC:
1605
AN:
5180
South Asian (SAS)
AF:
0.255
AC:
1228
AN:
4816
European-Finnish (FIN)
AF:
0.273
AC:
2880
AN:
10566
Middle Eastern (MID)
AF:
0.160
AC:
47
AN:
294
European-Non Finnish (NFE)
AF:
0.140
AC:
9526
AN:
67970
Other (OTH)
AF:
0.138
AC:
291
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1020
2040
3059
4079
5099
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
278
556
834
1112
1390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.137
Hom.:
1044
Bravo
AF:
0.140
Asia WGS
AF:
0.258
AC:
895
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Amyotrophic lateral sclerosis type 8 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Adult-onset proximal spinal muscular atrophy, autosomal dominant Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.26
CADD
Benign
16
DANN
Benign
0.93
PhyloP100
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1802459; hg19: chr20-57020573; COSMIC: COSV55669315; COSMIC: COSV55669315; API